Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the Heart Transplant market size evolved in recent years?

The size of the heart transplant market has seen significant acceleration in growth in the last few years. The market, which was worth $11.49 billion in 2024, is projected to increase to $12.66 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.2%. The expansion during the historical period is credited to factors like advancements in medical technology, enhanced knowledge and education, progress in organ preservation techniques, and the development of the healthcare infrastructure.

What are the predictions for the heart transplant market size in the coming years?

The market for heart transplants is anticipated to experience robust expansion in the coming years, forecasted to reach $18.1 billion by 2029 with a 9.3% compound annual growth rate (CAGR). This projected surge during the period is likely to be driven by factors such as government backing and finance, the internationalization of transplant schemes, the growth of the capacity of transplant centres, and the employment of telemedicine and distant observation methods. Key trends for this period are expected to include technological progress, artificial hearts and aid tools, along with the utilization of artificial intelligence (AI) in selecting donor organs.

Get your heart transplant market report here!

https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report

What key factors are fueling the growth of the heart transplant market?

The expected surge in cardiovascular diseases is anticipated to boost the heart transplant market’s growth over time. Cardiovascular diseases refer to various conditions impacting the heart and blood arteries. A heart transplant is the final treatment option for end-stage heart failure patients who haven’t found success with other treatments. Significantly, it improves the quality of life and extends longevity. For instance, as reported by the British Heart Foundation in September 2024, about 7.6 million people in the UK are affected by heart and circulatory diseases, including 4 million men and 3.6 million women. Predictions suggest that this number could rise by one million by 2030 and two million by 2040, over and above the present numbers. Consequently, the increasing instances of cardiovascular diseases will fuel the heart transplant market. The heart transplant market is forecasted to advance due to an increase in awareness about organ donation and transplantation. Such awareness pertains to the individual’s and communities’ comprehension, consciousness, and familiarity regarding organ donation and transplant processes’ importance and effects on healthcare. The rise in awareness about organ donation and transplantation notably affects the heart transplant sector by increasing the number of donors, reducing waiting times for recipients, and improving patient outcomes. For example, the United Network for Organ Sharing, a US-based non-profit educational and scientific institution, reported that a new yearly record of 42,887 organ transplants was set in the US in 2022, up 3.7% from 2021. In addition, due to increased awareness, liver transplants saw 9,528 procedures, heart transplants accounted for 4,111 surgeries, and lung transplants conducted 2,692 operations. Hence, the heart transplant market will be spurred by the growing awareness about organ donation and transplantation.

How is the global heart transplant market divided into key segments?

The heart transplant market covered in this report is segmented –

1) By Surgery Type: Total Artificial Heart, Biventricular Pacing, Ventricular Assist Devices, Other Surgery Types

2) By Transplant: Autograft, Allograft, Other Transplants

3) By End-User: Hospitals, Cardiac Institutes, Other End-Users

Subsegments:

1) By Total Artificial Heart: Temporary Total Artificial Heart, Permanent Total Artificial Heart

2) By Biventricular Pacing: Cardiac Resynchronization Therapy Pacemakers (CRT-P), Cardiac Resynchronization Therapy Defibrillators (CRT-D)

3) By Ventricular Assist Devices: Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (BIVAD)

4) By Other Surgery Types: Heart And Lung Transplant, Heterotopic Heart Transplant

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12967&type=smp

Who are the key firms paving the way for growth in the heart transplant market?

Major companies operating in the heart transplant market are Optum Inc., Novartis Pharmaceuticals UK Ltd., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Roche Diagnostics Ltd., Mayo Clinic, Cleveland Clinic, AstraZeneca PLC, Massachusetts General Hospital, Terumo Corp., NewYork-Presbyterian Hospital, Cedars-Sinai Medical Center, Maquet Holding B.V. and Co. KG., Teleflex Inc., Stanford Health Care, Johns Hopkins Hospital, Thoratec Corporation, Abiomed Inc., Baylor St. Lukes Medical Center, Transonic Systems Inc., Berlin Heart GmbH, HeartWare International Inc., SynCardia Systems LLC., Carmat SA, BiVACOR Inc., Apaxis Medical Inc., Calon Cardio-Technology Ltd., CardiacAssist Inc., The Texas Heart Institute.

Which trends are expected to transform the heart transplant market?

Leading corporations in the heart transplant market are concentrating their efforts on creating innovative solutions, such as heart preservation technology, to enhance patient results and the success rate of transplants. This advancement significantly lengthens the lifespan of the heart outside the body when compared to conventional ice storage, leading to improved results and fewer post-transplant issues. For example, XVIVO Perfusion AB, a medical technology firm located in Sweden, secured approval from the U.S. Food and Drug Administration (FDA) for a Investigational Device Exemption (IDE) application for its heart preservation technology in May 2023. This approval paved the way for the launch of the “PRESERVE Clinical Trial,” a prospective, multicenter, single-arm, open-label examination focused on studying hearts transplanted after non-ischemic heart preservation from extended donors, especially Donation after Circulatory Death (DCD) hearts. XVIVO’s heart preservation technology’s distinctive feature is its non-ischemic hypothermic perfusion system, which uses cold, oxygen-saturated perfusion to maintain donor hearts during transportation.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12967

What regions are contributing significantly to the growth of the heart transplant market?

North America was the largest region in the heart transplant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart transplant market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Cardiac Arrhythmia Monitoring Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-arrhythmia-monitoring-devices-global-market-report

Cardiac Biomarkers Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Cardiac Marker Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: